中國東方航空股份(00670.HK)3月旅客週轉量同比上升10.51%
格隆匯4月15日丨中國東方航空股份(00670.HK)公告,公司2025年3月客運運力投入(按可用座公里計)同比上升6.68%;旅客週轉量(按客運人公里計)同比上升10.51%;客座率爲84.16%,同比上升2.92個百分點。2025年3月貨郵週轉量(按貨郵載運噸公里計)同比上升11.10%。2025年3月,國內市場,公司新開上海浦東-延安、廈門-石家莊、長沙-濟南等航線,復航太原-廈門、佛山-昆明、青島-西寧等航線;國際市場,公司新開成都天府-大阪、煙臺-名古屋等航線。
2025年3月,公司引進4架A321NEO飛機,未退出飛機。截至2025年3月末,公司合計運營816架飛機。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.